Trial intelligence / Profile preview

Dual Sentinel Lymph Node Staining in Breast Cancer

NCT02479997Phase 2Completed

Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start
Mar 2015
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indocyanine green in breast cancer, sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

indocyanine green
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02479997.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02479997.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call